In the blood: Catching cancer before it strikes again

Cancer recurrence is often deadlier than the original disease, especially when it spreads undetected. Yet for survivors, post-treatment monitoring can be a financial, emotional and mental burden—relying on costly, invasive tests with no guarantees.  But what if detecting cancer was as simple as a blood test?  In this episode, Dr Debleena Ray, the founder of the biotech startup 2Strands Biosciences and a former Duke-NUS post-doctoral fellow, shares how she’s bridging research and entrepreneurship to develop cutting-edge, blood-based tests that will revolutionise cancer monitoring.    What’s inside this episode:  The story behind 2Strands Biosciences and Ray’s vision for the future of cancer detection  How her love for science began—and what fuels her passion  The leap from academia to entrepreneurship—and the lessons learned  Her advice for aspiring scientist-entrepreneurs looking to make an impact  Episode credits:  Hosted by: Brandon Raeburn, Media & Content Specialist  Produced by: Sean Firoz, Helmy bin Sa’at and Nicole Lim  To discover more scientific insights and personal stories from Singapore with impact on the world, go to: www.duke-nus.edu.sg/medicus